Otolaryngology

MedTech News for AngioDynamics, Ameda, Pfizer, Cochlear

Notizia - Recent Pharma, Healthcare and Biotech Happenings

AngioDynamics’s AlphaVac F18 PE System; Pfizer’s RSVpreF/PF-06928316 Trial; Intelligent Ultrasound’s ScanNav Anatomy PNB; FDA Approves the Cochlear Nucleus 8 Sound Processor; Ameda’s Pearl Breast Pump; J&J to Buy Abiomed; Thermo Fisher Scientific to Acquire The Binding Site Group

AngioDynamics Announces First Patient Enrolled in APEX-AV Study Assessing AlphaVac F18⁸⁵ PE System in Treatment of Pulmonary Embolism On October 31, 2022, AngioDynamics, a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, and improving the quality of life for patients, announced that the first patient has been enrolled in the Acute Pulmonary Embolism Extraction Trial with the AlphaVac System (APEX-AV). The study aims to evaluate the efficacy and safety of the Company’s AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 System in the treatment of a...

Explore More...